Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural photodynamic therapy with Photofrin plus multimodal treatment in malignant pleural mesothelioma
2015-001554-15Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of porfimer sodium in pleural mesothelioma, sponsored by CHU de Lille. Primary endpoint: Primary feasibility endpoint. Started Jul 2015; status: completed.
02
Drugs
porfimer sodium
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2015-001554-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001554-15.